Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...

One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.

University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically modifying HSV-1 and administering it to patients with treatment-resistant, ...

The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world's population and is generally ...

Chronic cutaneous herpes simplex, which is common in immunosuppressed patients, is characterized by atypical, chronic, and persistent lesions, which complicate and delay the diagnosis. [20, 21 ...

The cold sore-causing herpes simplex virus, HSV-1, is extremely common with an estimated 3.7 billion people already infected with it.

Scientists found that a genetically engineered herpes simplex virus, when combined with immunotherapy, reduced or eliminated tumors. The post Scientists successfully use herpes virus to treat skin ...

The herpes simplex virus, also known as HSV, is a viral infection that causes genital and oral herpes. Get the details on key signs, diagnosis, and treatment.

Herpes simplex virus-1 (HSV-1) is commonly known for causing blisters and sores. But in some cases, the virus can migrate to the eye or nervous system, causing severe, chronic symptoms.

Infectious disease researchers have used a gene editing approach to remove latent herpes simplex virus 1, or HSV-1, also known as oral herpes. In animal models, the findings show at least a 90 ...

Health Seattle virologists find promising new results for potential herpes cure: HealthLink Fred Hutch Cancer Center is researching gene therapy as a method to target herpes simplex virus infections ...